Who Paid My Doc
Aidar Gosmanov
Endocrinology, Diabetes & Metabolism Memphis, TN Medical Doctor
NPI 1316160872 CMS profile 286771
1407 Union Ave, Suite 200, Memphis, TN 38104
General payments
$138,289
Research payments
$16,049
Ownership & investment interest
$0
Research they led as principal investigator
$694,642
Through program year 2025, Aidar Gosmanov of Memphis, TN is reported in the CMS Open Payments database as having received $138,289 across 163 general payments and $16,049 in research payments paid to them. Separately, studies naming them as principal investigator received $694,642 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 94th percentile of Endocrinology, Diabetes & Metabolism profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $450 | 4 | |
| 2024 | General | $192 | 3 | |
| 2024 | Research | $14,663 | 1 | |
| 2023 | General | $125 | 2 | |
| 2023 | Research | $1,386 | 2 | |
| 2022 | General | $21,672 | 25 | |
| 2021 | General | $11,245 | 16 | |
| 2020 | General | $23,705 | 25 | |
| 2019 | General | $80,901 | 88 |
Beside peers
- Aidar Gosmanov
- Endocrinology, Diabetes & Metabolism median
- Middle half of Endocrinology, Diabetes & Metabolism
- National median
In program year 2025, general payments to Aidar Gosmanov were reported at $450. Among 5,868 Endocrinology, Diabetes & Metabolism profiles paid that year, the median was $507 and the middle half received between $135 and $1,838.
Show as a table
| Year | Aidar Gosmanov | Endocrinology, Diabetes & Metabolism median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $80,901 | $494 | $123–$2,253 | $163 |
| 2020 | $23,705 | $335 | $85–$1,841 | $114 |
| 2021 | $11,245 | $398 | $88–$1,981 | $132 |
| 2022 | $21,672 | $364 | $88–$1,568 | $149 |
| 2023 | $125 | $420 | $113–$1,614 | $160 |
| 2024 | $192 | $440 | $121–$1,646 | $164 |
| 2025 | $450 | $507 | $135–$1,838 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
166 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Endocrinology, Diabetes & Metabolism in Tennessee
Alan Cohen
Endocrinology, Diabetes & Metabolism · Memphis, TN
Craig Wierum
Endocrinology, Diabetes & Metabolism · Nashville, TN
Pascal Dauphin
Endocrinology, Diabetes & Metabolism · Hendersonville, TN
Shimon Harary
Endocrinology, Diabetes & Metabolism · Memphis, TN
Lisa Myers
Endocrinology, Diabetes & Metabolism · Germantown, TN
Amit Vora
Endocrinology, Diabetes & Metabolism · Knoxville, TN
Related records
Endocrinology, Diabetes & Metabolism in Tennessee
Practitioners in the same specialty and state, ranked by reported value.
All Endocrinology, Diabetes & Metabolism
Everyone recorded under this specialty, nationwide.
Doctors in Tennessee
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.